✦ LIBER ✦

128PD EGFR, KRAS, PIK3CA MUTATIONS AND RESPONSE TO TYROSINE KINASE INHIBITORS (TKIS) IN ADVANCED NSCLC PATIENTS

✍ Scribed by Crinò, L.; Pistola, L.; Bianconi, F.; Chiari, R.; Meacci, M.; Colella, R.; Giuffrida, D.; Tofanetti, F.R.; Flacco, A.; Ludovini, V.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

9162 EGFR, KRAS, PIK3CA mutations and re

✍ Chiari, R.; Ludovini, V.; Bianconi, F.; Pistola, L.; Colella, R.; Mameli, M.; Gi 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 51 KB

EGFR mutations in squamous NSCLC – Preva

✍ Berzinec, P.; Hlinkova, K.; Copakova, L.; Konecny, M.; Zavodna, K.; Cerna, M.; C 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 81 KB

Epidermal growth factor receptor (EGFR)

✍ Elena María Martínez-Navarro; Joseba Rebollo; Ramón González-Manzano; Manuel Sur 📂 Article 📅 2011 🏛 Springer Milan 🌐 Spanish ⚖ 230 KB

6522 POSTER EGFR mutations and response

✍ Crinó, L.; Ludovini, V.; Pistola, L.; Floriani, I.; Betti, M.; Chiari, R.; Giuff 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 57 KB

The use of first-generation tyrosine kin

✍ Riely, Gregory J. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 153 KB

Primary resistance to epidermal growth f

✍ Lee, J. K.; Shin, J.- Y.; Kim, S.; Lee, S.; Park, C.; Kim, J.- Y.; Koh, Y.; Keam 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 215 KB